Severe COVID-19 increases the risk of cardiovascular disease

Severe COVID-19 increases the risk of cardiovascular disease

Patients who have been hospitalised with severe COVID-19 have permanent changes in their cholesterol 3 months after recovery, according to a study from the University of Oslo. This increases their risk of developing heart disease later in life.

Many clinicians and scientists have wondered whether COVID-19 disease affects people’s health later in life. Several recent studies have shown that there is an association between COVID-19 and heart disease. Does being severely ill with COVID-19 increase people’s risk of developing heart disease?

“Recent studies have suggested that COVID-19 increases the risk of cardiovascular disease. However, the mechanisms for this are still unclear”, Ida Gregersen, a researcher at the University of Oslo and Oslo University Hospital, says.
Norwegian researchers have found that patients, who had been hospitalised with severe COVID-19, have permanent changes in their cholesterol after their recovery.
“We believe that COVID-19 increases the risk of developing heart disease later in life, and that these changes is a possible explanation for this increased risk”, Bente Halvorsen, Professor at the University of Oslo and the Principal Investigator of the study, says.

“Bad” LDL cholesterol increases the risk of heart disease
Cholesterol is one of the body's fatty substances and is an important building block in the body. There are different types of cholesterol, one of which is LDL, which is comprised of several LDL particles.
“LDL is responsible for transporting fat in the body and is sometimes called the “bad cholesterol”, Gregersen says.
It is called the bad cholesterol because high levels of LDL cholesterol in the blood raises your risk for heart disease and stroke.
“It is a well-known fact that the risk of cardiovascular disease increases with high levels of LDL in the blood. In addition, the risk also increases when there are changes in the composition of the LDL particles”, she says.

Changes in LDL particles seen in patients who has recovered from severe COVID-19
The researchers observed such changes in LDL composition in these patients, 3 month after they recovered from severe COVID-19.
“Patients who have had severe COVID-19 have had the composition of these LDL particles changed after their illness. Among other things, they contain several inflammatory substances”, says Gregersen.
Such changes can influence these LDL particles to collect in the walls of your blood vessels. This can drive the development of heart disease in the long term.
“We therefore believe that severe COVID-19 causes long-term changes in the composition of LDL particles, i.e. in the body's system for transporting fat around the body. It could potentially give the patients an increased risk of cardiovascular disease later, but we don't know that yet”, she says.

We can prevent heart disease when we know more about the risk
It is important that people who have had severe COVID-19 are aware of their increased risk of cardiovascular disease, according to the researchers.
“It is incredibly important that patients who have had severe COVID-19 know that they may have a changed composition of cholesterol in their body. We know from previous research that they have a greater risk of cardiovascular disease later in life”, Halvorsen says.
By identifying people who have an increased risk, it is possible to engage in preventive measures. Among other things, there are effective measures aimed at people with high levels of LDL cholesterol in their blood.
“The more we know, the more we can prevent and treat that risk. We have tools to treat the risk of heart disease in people with elevated LDL”, she says.

Lifestyle factors such as smoking and obesity are also important
Halvorsen recommends that those who have had severe COVID-19 disease follow up with their general practitioner. To find out if you have a higher risk of developing cardiovascular disease, you can ask for a blood test.
“We cannot say for sure that these patients actually will develop cardiovascular diseases. Environmental factors and lifestyle factors such as smoking, obesity and high blood pressure will play a role in whether this will develop further”, Halvorsen says.

New method can isolate and measure changes in LDL particles
The researchers have investigated a specific characteristic of the LDL particles, so-called LDL aggregation, which is when the LDL particles group together in the blood vessels. To investigate LDL aggregation, the researchers collaborated with the Wihuri Research Institute in Finland that have established a method that can isolate and measure these changes in LDL.
“We know that LDL can aggregate, i.e. group together. However, this method can obtain quantitative measures that can demonstrate whether there is a change in LDL aggregation in the blood. We can therefore use this as a measure of risk for cardiovascular”, Halvorsen explains.

Persistent changes in LDL indicate an active immune activation
“The fact that these differences in LDL composition are seen 3 months after patients recovered from COVID-19, is important”, Halvorsen points out.
LDL has a plasma half-life of only a few days before it is renewed. Half-life means the time it takes for LDL to decrease by half. After a few days, new LDL is produced. Normally, one would thus expect the changes in LDL composition to disappear after a few days.
“When we still see changes in LDL composition after 3 months, it suggests that COVID-19 can lead to long-term disturbances in the system that transports fat in our body. In addition, the LDL carries inflammatory markers. This shows us that there is still immune activation in the body 3 months after recovering from COVID-19”, Halvorsen explains. The professor believes the findings are surprising.
“We saw significant differences in the way LDL grouped together, between healthy people who did not have COVID-19, and these patients, who had been ill and hospitalised with severe COVID-19. For me, this is quite sensational. This is a new finding, and it will be interesting to see how this develops further”, Halvorsen says.

Analysed blood samples from the first COVID-19 patients in Norway
The researchers analysed blood samples from 66 people who had been hospitalised with severe COVID-19, taken during a check-up 3 months after being discharged from hospital. These patients were hospitalised during the first wave of COVID-19 in March 2020. The researchers then compared these samples with 42 healthy adults who served as controls, and checked whether factors such as age, gender and ethnicity played a role.

More research is needed
“Our data suggest new mechanisms for increased cardiovascular risk in COVID-19 patients. However, further and larger studies that can examine the association between these LDL characteristics and the development of cardiovascular diseases, is needed to support our findings further”, Halvorsen concludes.

T. Ueland, L.A.O. Äikäs, T.B. Dahl et al., Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization, Journal of Infection, j.jinf.2023.02.024i
Regions: Europe, Norway, Finland
Keywords: Covid-19, Covid-19, Health, Medical


For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...

  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2023 by AlphaGalileo Terms Of Use Privacy Statement